Jefferies Maintains Buy on Five Below, Raises Price Target to $300

Jefferies analyst Randal Konik maintains Five Below (NASDAQ:FIVE) with a Buy and raises the price target from $260 to $300.

byBenzinga Newsdesk

June 4, 2021

1 minute read

Jefferies analyst Randal Konik maintains Five Below (NASDAQ:FIVE) with a Buy and raises the price target from $260 to $300.

News
Tech

Tesla China Team Gets Elon Musk’s Praise As Giga Shanghai Said To Have Begun Mass-Producing Model Y

By Rachit Vats

Today, 8:03 PM

Tesla Inc’s (NASDAQ: TSLA) China team won some praise from CEO Elon Musk after a fan posted a milestone for the electric vehicle maker’s gigafactory in Shanghai.

TSLA

Cocrystal Pharma Has Been Granted European Patent Number EP3866778 Titled “Combinations Of Inhibitors Of Influenza Virus Replication”

By Benzinga Newsdesk

Today, 8:03 PM

About this file - European Patent Register (epo.org) (2) PatentGrants on Twitter: "$COCP Cocrystal Pharma has been granted European patent number EP3866778 titled "COMBINATIONS OF INHIBITORS OF INFLUENZA VIRUS

COCP

News

Cytek Biosciences Highlights Introduction Of New 25-Color Immunoprofiling Assay

By Benzinga Newsdesk

Today, 8:03 PM

The field of medical research has a new tool to develop vaccines, personal immunotherapies, and cures for cancer and other infectious diseases using Full Spectrum Profiling™ (FSP™) technology. Cytek

CTKB

Piper Sandler Upgrades First Midwest Bancorp to Overweight, Raises Price Target to $22.67

By Benzinga Newsdesk

Today, 8:03 PM

Piper Sandler analyst Nathan Race upgrades First Midwest Bancorp (NASDAQ:FMBI) from Neutral to Overweight and raises the price target from $20.4 to $22.67.

FMBI

Jefferies Maintains Buy on Five Below, Raises Price Target to $300

Related Posts

Tesla China Team Gets Elon Musk’s Praise As Giga Shanghai Said To Have Begun Mass-Producing Model Y

Cocrystal Pharma Has Been Granted European Patent Number EP3866778 Titled “Combinations Of Inhibitors Of Influenza Virus Replication”

Cytek Biosciences Highlights Introduction Of New 25-Color Immunoprofiling Assay

Piper Sandler Upgrades First Midwest Bancorp to Overweight, Raises Price Target to $22.67